Business

Is It Time for This95-Year-Old Pianist to Retire?

Her vision and hearing are deteriorating, but she still wants to feel like she’s on top.

Read full story on The New York Times →

Sarah Kramer and Shuran Huang25 Aug 2026, 11:12 amUpdated 2h ago1 min readBusinessGlobal

Global — Sarah Kramer and Shuran Huang

Is It Time for This 95-Year-Old Pianist to Retire?

Her vision and hearing are deteriorating, but she still wants to feel like she’s on top.

This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times →

Source: The New York Times · Sarah Kramer and Shuran Huang. Published 25 Aug 2026, 11:12 am.

Next news → Many N.F.L. Players Get Brain Disease. Why…Browse more stories

Keep reading

Most relevant

Many N.F.L. Players Get Brain Disease. Why Hasn’t OSHA Intervened?

“We never see things that are this dire,” a former chief scientist of the agency said about rates of C.T.E. in former players.

Read on The New York Times →

Editor’s choice

Gold hits highest level in three months as traders worry about US inflation and bond market jitters – business live

Spot gold touches almost $4,700 an ounce and Bitcoin tops $80,000 while oil prices fall despite threat of heavy US sanctions on Iran and any country trading with it

Read on theguardian.com →

Also developing

Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn

eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.

Read on The Hindu →

Back to the desk

info@ebenezerdigital.com +91 98944 96560 WhatsApp